A Personal COVID Vaccine Experience

We were doing our part to help facilitate making the vaccine available to the public.

I was feeling confined and socially distanced due to COVID-19, as many of us are – and anxious for a vaccine so I could get back to a more normal life. I had heard about vaccine trials on the national news, so I did some research on the Internet about them. The closest clinical trials were 70 miles from where I live. My husband encouraged me to get more information, so I called the clinical trial phone number, and they sent us paperwork to complete.

We felt that enrolling in a trial would help facilitate the process of making a vaccine available to the public. We knew participants for clinical trials were needed. I also was hoping to get a vaccine as soon as possible. We began this process in September, when Moderna and Pfizer were in third-phase clinical trials. We were both eligible, and it was determined by the research center in Jacksonville, Florida that we would be in the Pfizer trial, as we were adhering to the Centers for Disease Control and Prevention (CDC) recommendations for social distancing and wearing masks.

We had an initial phone interview and were sent forms via email. We completed a medical history form and current medication list, and signed a consent. We had a phone interview during which I asked several questions, including “what happens if we get placebo?”, “when can we get the actual vaccines?”, “if the Pfizer vaccine is not approved, can we get an approved vaccine when one becomes available?”, and “how long will the trial last?” We were given information about our commitment, which is two years, and were accepted into the Pfizer clinical trial.

In early October, I drove to Jacksonville, where I met with the staff at the clinical research center. I was interviewed by a staff member, had vital signs taken, and received a brief physical by a physician. I signed a lengthy consent form, had a COVID test, and received my first injection in the beginning of October. My husband received his a week later. We were given a kit with a thermometer, a COVID test, instructions for an app to keep a weekly diary, and contact information in case we developed COVID symptoms..

I received the second injection three weeks later, and had at least two subsequent appointments for follow-up physicals, additional COVID tests, labs, and interviews. My husband had similar visits, and one additional visit after he had one possible vague COVID symptom, which he reported. When this happened, he called the research center, and he was instructed to do a COVID test. I was positive he didn’t have COVID, but we followed protocol.

When I received the two injections, I did not have any symptoms, while my husband had dizziness for a few days, which was worse after the second injection. This led me to believe that I likely had received the placebo, and he had received the actual vaccine. This study was blinded, and we were unable to verify this. The staff thought we might be a priority for the vaccine if we received the placebo when I inquired, but we did not have this in writing, as it was not confirmed.

When the vaccine was approved for emergency use and nurses were able to be vaccinated in Georgia, I called the research center to inquire if I received the vaccine or placebo. The vaccine was available where I worked, and I was anxious to have this information. About two weeks later and after several calls, my case was unblinded, I determined I had not received the vaccine, and then I was given an appointment to receive one on Dec. 22. It was a great Christmas present!

My husband’s study was to be blinded until his next appointment, but that later changed. We recently learned that he did get the Pfizer vaccine in October!

Most of our follow-up at this point will be via phone, and we continue to complete our weekly diaries. When we have spoken to friends, some people are interested in our experience and appreciative for our efforts, and others joke about us being guinea pigs. We feel we were only trying to do our part to help facilitate making the vaccine available to the public.

Programming Note: Listen to Carol Lester report this story live today during Talk Ten Tuesdays, 10 a.m. Eastern.

Print Friendly, PDF & Email
Facebook
Twitter
LinkedIn

Related Stories

Spring Brings Code Meetings and Updates

Spring Brings Code Meetings and Updates

We are approaching April 1, which means that ICD-10-CM and ICD-10-PCS will be updated with their respective guidelines. The Centers for Disease Control and Prevention

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Leveraging the CERT: A New Coding and Billing Risk Assessment Plan

Leveraging the CERT: A New Coding and Billing Risk Assessment Plan

Frank Cohen shows you how to leverage the Comprehensive Error Rate Testing Program (CERT) to create your own internal coding and billing risk assessment plan, including granular identification of risk areas and prioritizing audit tasks and functions resulting in decreased claim submission errors, reduced risk of audit-related damages, and a smoother, more efficient reimbursement process from Medicare.

April 9, 2024
2024 Observation Services Billing: How to Get It Right

2024 Observation Services Billing: How to Get It Right

Dr. Ronald Hirsch presents an essential “A to Z” review of Observation, including proper use for Medicare, Medicare Advantage, and commercial payers. He addresses the correct use of Observation in medical patients and surgical patients, and how to deal with the billing of unnecessary Observation services, professional fee billing, and more.

March 21, 2024
Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets

Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets

Explore the top-10 federal audit targets for 2024 in our webcast, “Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets,” featuring Certified Compliance Officer Michael G. Calahan, PA, MBA. Gain insights and best practices to proactively address risks, enhance compliance, and ensure financial well-being for your healthcare facility or practice. Join us for a comprehensive guide to successfully navigating the federal audit landscape.

February 22, 2024
Mastering Healthcare Refunds: Navigating Compliance with Confidence

Mastering Healthcare Refunds: Navigating Compliance with Confidence

Join healthcare attorney David Glaser, as he debunks refund myths, clarifies compliance essentials, and empowers healthcare professionals to safeguard facility finances. Uncover the secrets behind when to refund and why it matters. Don’t miss this crucial insight into strategic refund management.

February 29, 2024
2024 ICD-10-CM/PCS Coding Clinic Update Webcast Series

2024 ICD-10-CM/PCS Coding Clinic Update Webcast Series

HIM coding expert, Kay Piper, RHIA, CDIP, CCS, reviews the guidance and updates coders and CDIs on important information in each of the AHA’s 2024 ICD-10-CM/PCS Quarterly Coding Clinics in easy-to-access on-demand webcasts, available shortly after each official publication.

April 15, 2024

Trending News

SPRING INTO SAVINGS! Get 21% OFF during our exclusive two-day sale starting 3/21/2024. Use SPRING24 at checkout to claim this offer. Click here to learn more →